Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India

Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors

(2015) David R. Deyle et al.   GENE

Identification of new sub-genotypes of virulent Newcastle disease virus with potential panzootic features

(2015) Patti J. Miller et al.   INFECTION GENETICS AND EVOLUTION

Characterization of an Oncolytic Herpes Simplex Virus Drug Candidate

(2015) Ozan S. Kumru et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Newcastle disease virus outbreaks in India: Time to revisit the vaccine type and strategies

(2015) Sachin Kumar   VACCINE

Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus

(2015) Michael C Brown et al.   Current Opinion in Virology

Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy

(2014) Fu-Liang Bai et al.   CANCER BIOLOGY & THERAPY

Vaccination influences the evolution of classical swine fever virus

(2014) Wei Ji et al.   INFECTION GENETICS AND EVOLUTION

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

(2014) Carolien A. Koks et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis

(2014) Anandan Paldurai et al.   PLoS One

Newcastle disease virus: Current status and our understanding

(2014) Ketan Ganar et al.   VIRUS RESEARCH

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo

(2014) Dongyun He et al.   Viruses-Basel

Complete genome sequencing and analysis of an anti-tumor Newcastle disease virus strain

(2013) Kaiyang Liu et al.   GENE

Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus

(2011) Jianchun Bian et al.   ARCHIVES OF VIROLOGY

Newcastle disease virus: A promising agent for tumour immunotherapy

(2011) Lixiang Zhao et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy

(2011) Han Yuen Lam et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Use of attenuated paramyxoviruses for cancer therapy

(2010) Patrycja J Lech et al.   Expert Review of Vaccines

Complete genome characterisation of a Newcastle disease virus isolated during an outbreak in Sweden in 1997

(2010) Anna-Malin Linde et al.   VIRUS GENES

The Effect of Vaccination on the Evolution and Population Dynamics of Avian Paramyxovirus-1

(2010) Yee Ling Chong et al.   PLoS Pathogens

Genetically engineered Newcastle disease virus for malignant melanoma therapy

(2009) D Zamarin et al.   GENE THERAPY

Newcastle disease outbreaks in Kazakhstan and Kyrgyzstan during 1998, 2000, 2001, 2003, 2004, and 2005 were caused by viruses of the genotypes VIIb and VIId

(2009) Andrey Bogoyavlenskiy et al.   VIRUS GENES

The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma

(2008) Ta-Chiang Liu et al.   MOLECULAR THERAPY

Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region

(2008) Sachin Kumar et al.   VIRUS RESEARCH

Characterization of the genome sequence of an oncolytic Newcastle disease virus strain Italien

(2008) Ding Wei et al.   VIRUS RESEARCH

Nuclear translocation of p65 NF-κB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction

(2007) Mourad Zerfaoui et al.   CELLULAR SIGNALLING